These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 18376265

  • 1. Hearing loss in pediatric oncology patients receiving carboplatin-containing regimens.
    Dean JB, Hayashi SS, Albert CM, King AA, Karzon R, Hayashi RJ.
    J Pediatr Hematol Oncol; 2008 Feb; 30(2):130-4. PubMed ID: 18376265
    [Abstract] [Full Text] [Related]

  • 2. Platinum compound-related ototoxicity in children: long-term follow-up reveals continuous worsening of hearing loss.
    Bertolini P, Lassalle M, Mercier G, Raquin MA, Izzi G, Corradini N, Hartmann O.
    J Pediatr Hematol Oncol; 2004 Oct; 26(10):649-55. PubMed ID: 15454836
    [Abstract] [Full Text] [Related]

  • 3. Incidence of platinum-induced ototoxicity in pediatric patients in Quebec.
    Peleva E, Emami N, Alzahrani M, Bezdjian A, Gurberg J, Carret AS, Daniel SJ.
    Pediatr Blood Cancer; 2014 Nov; 61(11):2012-7. PubMed ID: 24976616
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.
    van As JW, van den Berg H, van Dalen EC.
    Cochrane Database Syst Rev; 2014 Jul 01; (7):CD009219. PubMed ID: 24984156
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Ototoxicity in children receiving platinum chemotherapy: underestimating a commonly occurring toxicity that may influence academic and social development.
    Knight KR, Kraemer DF, Neuwelt EA.
    J Clin Oncol; 2005 Dec 01; 23(34):8588-96. PubMed ID: 16314621
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Hearing loss among survivors of childhood brain tumors treated with an irradiation-sparing approach.
    Orgel E, Jain S, Ji L, Pollick L, Si S, Finlay J, Freyer DR.
    Pediatr Blood Cancer; 2012 Jun 01; 58(6):953-8. PubMed ID: 21796767
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Incidence and associated risk factors for platinum-induced ototoxicity in pediatric patients.
    Waissbluth S, Del Valle Á, Chuang A, Becker A.
    Int J Pediatr Otorhinolaryngol; 2018 Aug 01; 111():174-179. PubMed ID: 29958605
    [Abstract] [Full Text] [Related]

  • 17. Assessment of hearing in very young children receiving carboplatin for retinoblastoma.
    Smits C, Swen SJ, Theo Goverts S, Moll AC, Imhof SM, Schouten-van Meeteren AY.
    Eur J Cancer; 2006 Mar 01; 42(4):492-500. PubMed ID: 16376542
    [Abstract] [Full Text] [Related]

  • 18. Analysis of ototoxicity in young children receiving carboplatin in the context of conservative management of unilateral or bilateral retinoblastoma.
    Jehanne M, Lumbroso-Le Rouic L, Savignoni A, Aerts I, Mercier G, Bours D, Desjardins L, Doz F.
    Pediatr Blood Cancer; 2009 May 01; 52(5):637-43. PubMed ID: 19148943
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Hearing impairment after platinum-based chemotherapy in childhood.
    Einar-Jon E, Trausti O, Asgeir H, Christian M, Thomas W, Måns M, Jon K, Hannes P.
    Pediatr Blood Cancer; 2011 Apr 01; 56(4):631-7. PubMed ID: 21298751
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.